Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

AXL expression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

AXL expression	Non Small Cell Lung Cancer	AXL expression	Non Small Cell Lung Cancer	pembrolizumab + BGB324 Sensitive: C2 – Inclusion Criteria pembrolizumab + BGB324 Sensitive : C2	pembrolizumab + BGB324 Sensitive: C2 – Inclusion Criteria pembrolizumab + BGB324 Sensitive : C2
AXL expression	Colorectal Cancer	AXL expression	Colorectal Cancer	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3	cetuximab Resistant: C3 – Early Trials cetuximab Resistant : C3
AXL expression	Melanoma	AXL expression	Melanoma	ipilimumab Resistant: C3 – Early Trials ipilimumab Resistant : C3	ipilimumab Resistant: C3 – Early Trials ipilimumab Resistant : C3
AXL expression	Renal Cell Carcinoma	AXL expression	Renal Cell Carcinoma	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3	nivolumab Resistant: C3 – Early Trials nivolumab Resistant : C3
AXL expression	Non Small Cell Lung Cancer	AXL expression	Non Small Cell Lung Cancer	gefitinib Resistant: C3 – Early Trials gefitinib Resistant : C3	gefitinib Resistant: C3 – Early Trials gefitinib Resistant : C3
AXL expression	Renal Cell Carcinoma	AXL expression	Renal Cell Carcinoma	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D	sunitinib Sensitive: D – Preclinical sunitinib Sensitive : D